Results 271 to 280 of about 449,894 (358)

Elastase-alpha1-proteinase inhibitor complex [PDF]

open access: yes, 1984
Bergmeyer, H. U.   +4 more
core   +1 more source

Differential Immune Cell Infiltration in Eosinophilic and Non‐Eosinophilic CRS: Correlations With Clinical, Endoscopic, and Radiological Findings

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background The pathogenesis of inflammation in eosinophilic chronic rhinosinusitis (ECRS) and non‐eosinophilic chronic rhinosinusitis (NECRS) remains poorly understood. This study aimed to assess immune cell infiltration within the sinonasal microenvironment in these conditions.
Katarzyna Czerwaty   +5 more
wiley   +1 more source

Pulmonary artery thrombosis in preterm infants born to a diabetic mother: a case report. [PDF]

open access: yesJ Med Case Rep
Xiangyun Y   +5 more
europepmc   +1 more source

A study on the variation of cytokine and electrolyte levels in rhesus macaques, cynomolgus monkeys, and Assamese macaques

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This study aims to investigate the variations in cytokine and electrolyte levels among rhesus macaques, cynomolgus monkeys, and assamese macaques in terms of species, sex, and age. By assessing 23 immune function indicators and 5 electrolyte indicators, significant differences in cytokine and electrolyte levels were detected across different monkey ...
Suqin Duan   +12 more
wiley   +1 more source

The preoperative coagulation pattern in liver transplant patients [PDF]

open access: yes, 1986
Bontempo, FA   +3 more
core  

Krüppel‐like factor 4 transcription factor in blood–brain barrier endothelial cells: A potential role in Alzheimer's disease

open access: yesAnimal Models and Experimental Medicine, EarlyView.
KLF4 (Krüppel‐like factor 4) plays a protective role in blood–brain barrier (BBB). KLF4 plays an ambiguous role in the central nervous system. KLF4 in the BBB endothelial cells could be a potential target for Alzheimer's disease. Abstract Alzheimer's disease is the most prevalent chronic neurodegenerative disorder worldwide, with no sufficient cure ...
Ziying Wei   +4 more
wiley   +1 more source

Intravenous Thrombolysis in Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset: Results from the Safe Implementations of Treatments in Stroke International Stroke Registry

open access: yesAnnals of Neurology, EarlyView.
Objectives Intravenous thrombolysis (IVT) is contraindicated for acute ischemic stroke (AIS) patients taking direct oral anticoagulants (DOACs) within 48 hours before index stroke. Limited data exist on off‐label use of IVT for these patients. We compared the safety and outcomes of IVT in AIS patients with DOAC treatment and patients with no OAC before
Marius Matusevicius   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy